Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$BIIB

Biogen Inc. Common Stock

XNASHealth CareBiological Products, (No Diagnostic Substances)

$210.74+0.87%+$1.82Prev $208.92LIVE Full chart Live alerts
No recent price bars, the chart lights up when BIIB starts printing.

As of the latest tick, BIIB is trading at $210.74, up 0.87% versus the previous close of $208.92. Our scanner has flagged BIIB 36 times on unusual volume in the last 30 days.

Key Stats

Price & performance
Price
$210.74
Change today
+0.87%
Previous close
$208.92
52-week range
$121.05 – $219.72
Valuation & dividend
Market cap
$30.84B
Ownership & volume
Shares outstanding
147.6M
SEC · as of 2026-04-27
Insider ownership
<1%
DEF 14A · 2026-04-28
Institutional own.
208.39%
Short interest
5.7M
▲ +10% vs prior · as of 2026-06-30
Short % of float
3.9%
Days to cover
4.1d
Avg daily volume
1.5M
Next earnings
Jul 29 · in 11d (before open)
Classification
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
XNAS

Get free BIIB + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $BIIB up today?

Here is the latest on BIIB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BIIB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystResults of Operations, from the latest SEC filing. Read it →
Why is $BIIB moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy28 analysts
Avg target $222.67(+6% upside)
Range $157 – $260
18 buy9 hold1 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying9 buys, 1 sells last 3 months (10/20 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Freire Maria C
Director
Acquired (grant/award)+2Kadded 29%9Kn/aJun 9, 26
Minor Lloyd
Director
Acquired (grant/award)+2Kadded 64%4Kn/aJun 9, 26
Pangalos Menelas N
Director
Acquired (grant/award)+2Kadded 64%4Kn/aJun 9, 26
Pangalos Menelas N
Director
Other2Kn/a2Kn/aJun 9, 26
Patolawala Monish D
Director
Acquired (grant/award)+2Kadded 41%5Kn/aJun 9, 26
Langer Susan
Director
Acquired (grant/award)+2Kadded 29%7Kn/aJun 9, 26
Mantas Jesus B
Director
Acquired (grant/award)+2Kadded 15%11Kn/aJun 9, 26
Rowinsky Eric K
Director
Acquired (grant/award)+2Kadded 6.2%26Kn/aJun 9, 26
Sherwin Stephen A
Director
Acquired (grant/award)+2Kadded 11%15Kn/aJun 9, 26
Hawkins William A
Director
Acquired (grant/award)+2Kadded 17%10Kn/aJun 9, 26
Keeney Adam
Officer
Sold (automatic/other)-455sold 6.7%6K$85K
at $187.06
May 1, 26
Keeney Adam
Officer
Other939added 16%7Kn/aMay 1, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$BIIB Sentiment

Bullish
Bearish62Bullish
📰 News: 4 bull · 2 bearToday: +0.9%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$BIIB Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 2d ago +4.1% vs EMA
BIIB 200EMA (5m) Trending · 71 bars · L3 · +4.06% above EMA · slope +0.78%
at $209.12
Alert· 2d ago +1.4% vs EMA
BIIB 50EMA (5m) Trending · 71 bars · L3 · +1.43% above EMA · slope +1.10%
at $209.12
Alert· 2d ago +1.4% vs EMA
BIIB 200EMA (1m) Trending · 279 bars · L5 · +1.41% above EMA · slope +0.22%
at $209.12
Alert· 2d ago 2.0× RVOL
BIIB hit 2.000x RVOL at 3:43 PM ET
at $207.96
Alert· 2d ago +0.9% vs EMA
$BIIB near 200 EMA: +0.89% from 200 EMA at 2:42 PM ET
at $207.91
Alert· 2d ago 2.9× RVOL
BIIB hit 2.915x RVOL at 2:42 PM ET
at $207.91
Alert· 2d ago +1.7% vs EMA
$BIIB near 200 EMA: +1.66% from 200 EMA at 1:25 PM ET
at $207.25
Alert· 2d ago 6.3× RVOL
BIIB hit 6.329x RVOL at 1:25 PM ET
at $207.25
Alert· 2d ago +1.4% vs EMA
$BIIB near 200 EMA: +1.36% from 200 EMA at 12:52 PM ET
at $205.50
Alert· 2d ago 3.4× RVOL
BIIB hit 3.409x RVOL at 12:52 PM ET
at $205.50
Alert· 2d ago
The Watcher (dev) BOUGHT $BIIB at $204.8400 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher breakout strategy","reason":"double_bottom · lows $194.84 · neckline $198.53 · tgt $230.39 · R/R 2.00","gameTradeId":"3252c472-080b-488d-9aad-3b76fd362562","entryPrice":204.84,"shares":0.04881859011911736,"positionSizePct":1,"rvolContext":0.24548659667690556,"stopRule":"Watcher exits: chandelier −3×ATR · hard stop −1.5×ATR · 60d hold cap","instance":"WatcherPaper"}
at $204.84
Alert· 2d ago
The Watcher BOUGHT $BIIB at $204.5000 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher breakout strategy","reason":"double_bottom · lows $194.84 · neckline $198.53 · tgt $230.11 · R/R 2.04","gameTradeId":"2487120f-f378-44de-b901-f6d95069688f","entryPrice":204.5,"shares":0.0488997555012225,"positionSizePct":1,"rvolContext":0.24452892036190738,"stopRule":"Watcher exits: chandelier −3×ATR · hard stop −1.5×ATR · 60d hold cap","instance":"Watcher"}
at $204.50
Alert· 2d ago +1.5% vs EMA
$BIIB near 200 EMA: +1.46% from 200 EMA at 12:20 PM ET
at $204.74
Alert· 2d ago 4.2× RVOL
BIIB hit 4.189x RVOL at 12:20 PM ET
at $204.74
Alert· 2d ago +0.2% vs EMA
BIIB 50EMA (1m) Trending · 103 bars · L4 · +0.18% above EMA · slope +0.52%
at $204.94
Alert· 2d ago 2.7× RVOL
BIIB hit 2.658x RVOL at 11:25 AM ET
at $205.31
Alert· 3d ago 23.3× RVOL
BIIB hit 23.340x RVOL at 3:53 PM ET
at $197.83
Alert· 3d ago +1.3% vs EMA
$BIIB near 200 EMA: +1.28% from 200 EMA at 2:53 PM ET
at $197.52
Alert· 3d ago 3.2× RVOL
BIIB hit 3.207x RVOL at 2:53 PM ET
at $197.52
Alert· 3d ago +1.0% vs EMA
$BIIB near 200 EMA: +1.02% from 200 EMA at 2:19 PM ET
at $196.84
Alert· 3d ago 8.8× RVOL
BIIB hit 8.773x RVOL at 2:19 PM ET
at $196.84
Alert· 3d ago 10.6× RVOL
BIIB hit 10.570x RVOL at 1:15 PM ET
at $195.35
News· GlobeNewswire Inc.· 3d ago Bullish
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider
Alert· 4d ago 7.6× RVOL
BIIB hit 7.602x RVOL at 3:00 PM ET
at $194.35
Alert· 4d ago +0.5% vs EMA
$BIIB near 200 EMA: +0.53% from 200 EMA at 2:33 PM ET
at $194.99
Alert· 4d ago 4.8× RVOL
BIIB hit 4.804x RVOL at 2:33 PM ET
at $194.99
News· GlobeNewswire Inc.· 12d ago Neutral
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
News· The Motley Fool· 14d ago Bullish
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
News· SEC EDGAR· 17d ago
BIOGEN INC. filed an 8-K: Results of Operations
News· GlobeNewswire Inc.· 19d ago Bearish
Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIB
News· GlobeNewswire Inc.· 25d ago Bearish
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
News· GlobeNewswire Inc.· 26d ago Bullish
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
News· Benzinga· 30d ago Bullish
Biogen To Acquire RayThera For Up To $1 Billion, Expanding Immunology Pipeline

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

Free alerts

Get free $BIIB alerts the moment volume spikes

Our scanner flagged $BIIB 36 times in the last 30 days. Create a free account to track $BIIB, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

BIIB stock FAQ

Why is $BIIB up today?

Here is the latest on BIIB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BIIB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the BIIB stock price today?

BIIB last traded at $210.74, up 0.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live BIIB alerts?

The BIIB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BIIB 36 times in the last 30 days.

What exchange is BIIB on?

BIIB (Biogen Inc. Common Stock) trades on XNAS, with a market cap of about $30.84B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.

Is BIIB good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BIIB for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.